DGICB Overview

Dividend Declaration: Donegal Group Inc. announced a quarterly cash dividend of $0.1825 per share for Class A common stock and $0.165 per share for Class B common stock, payable on November 17, 2025, to stockholders of record by November 3, 2025.

Company Overview: Donegal Group Inc. is an insurance holding company operating in 21 states, offering property and casualty insurance, and is rated A (Excellent) by A.M. Best. The company focuses on financial performance, operational modernization, profitable growth, and enhancing experiences for agents, customers, and employees.

Earnings Release Announcement: Donegal Group Inc. will release its third-quarter results for the period ending September 30, 2025, on October 30, 2025, before NASDAQ trading begins, along with a supplemental investor presentation on its website.

Management Commentary and Q&A Session: A pre-recorded audio webcast featuring management commentary will be available at 8:30 am ET on the same day, followed by a Q&A session where questions can be submitted via email until October 23, 2025.

Celestica's Financial Performance: Celestica Inc. shares surged 12.1% in pre-market trading after reporting second-quarter earnings of $1.39 per share, exceeding analyst expectations, and raising its FY25 guidance along with third-quarter estimates.

Market Movements: Several stocks experienced significant pre-market trading movements, with Salarius Pharmaceuticals gaining 279.1%, while AIM ImmunoTech saw a decline of 40.9% following disappointing trial data.

Q2 Financial Performance: Donegal Group reported a Q2 Non-GAAP EPS of $0.43 and a GAAP EPS of $0.46, with net premiums earned decreasing by 1.1% to $231.8 million and a combined ratio improving to 97.7% from 103.0%.

Book Value Growth: The book value per share increased to $16.62 as of June 30, 2025, up from $14.48 on the same date in 2024, indicating positive margin growth and increasing dividend yields.